POSTER SESSIONS

POSTER SESSIONS DETAILS

Click to Download Brochure Present your research at the Ubiquitin Conference 2009 and take the chance to showcase your results to hundreds of ubiquitin leaders from the top Academica, Biotechnology, Government and Pharmaceutical institutions! 

Accepted Posters:
 
1. Frank Bruzzese - "Development of a Charcoal Paper ATP: Pyrophosphate Exchange Assay: Kinetic Characterization of NEDD8 Activating Enzyme"

2. Ceshi Chen - "The WWP1 E3 Ubiquitin Ligase as a Novel Molecular Target in Breast Cancer"

3. Jesse Chen - "Synthesis and Inhibition Studies of Ubiquitin Adenosine Sulfamate Adduct with UBL Activating Enzymes"

4. Margaret Chou - "TRE17/Ubiquitin-Specific Protease 6 Translocated in Aneurysmal Bone Cyst Induces Matrix Proteinase and Cytokine Production through Activation of NFĸB"

5. Neal Cosby - "Sensitive, Homogeneous, Bioluminescent Assays for Monitoring Proteases of the Ubiquitin-Proteasome Pathway"

6. Sirano Dhe-Paganon - "The E3 ligase UHRF1 Contains a Cryptic Tandem Tudor Domain that Recognizes Hallmarks of Heterochromatin"

7. Bruce Dorsey - "CEP-18770: Discovery of a Potent, Selective and Orally Active Proteasome Inhibitor for the Treatment of Cancer"

8. Mike Eddins - "Identification and Characterization of MuRF1 Inhibitors to Treat Myopathy"

9. Mayra Garcia - "The Ubiquitin-Proteasome Pathway In Hepatitis B Virus Replication, Trafficking, And Release"

10. Andy Golden - "Mutations in the Anaphase-Promoting Complex and its Regulators Affect the Meiotic Divisions in C. elegans"

11. Seth Hayik -  "Method For Detection Of A Ubiquitin Specific Protease 7 Inhibitor using De Novo In Silico Techniques"

12. Alexey Ivanov - "Different conjugation efficiency of various UBLs to endogenous total proteins in transfected human cells"

13. Stephanie Justice-Bitner - "The Role of Mu-Opioid Interacting Proteins in Drug Addiction"

14. Holger Karmer - "Characterization of Deubiquitylating Enzymes and Cellular Effects of their Inhibition"

15. Aster Legesse Miller - "Protein Catabolism in Quiescent Fibroblasts"

16. Suixing Liu - "A Potential New Target for Cancer Therapy: Ubiquitin Conjugating Enzyme UbcH5"

17. Lindsey Mayo - "c-Abl Contributes to Mdm2-Mdmx Complex Formation Protecting p53 Levels"

18. Danilo Milardi - "The Inorganic Side of Ubiquitin"

19. Junmin Peng - "Proteomics Approaches to Ubiquitome"

20. Elizabeth Ponder - "Identification of a Small Molecule Inhibitor of PfSENP1, a SUMO Deconjugating Protease of Plasmodium Falciparum"

21. Venuprasad Poojary - "E3 Ubiquitin Ligase Itch Regulates Foxp3 Expression and Airway Inflammation by Modulating TIEG1"

22. Paul Sheppard - "Analysis of Lys63-linked Polyubiquitinylation in Neurodegeneration"

23. Yilin Yan - "Human USP18 is a DeISGinylase: Expression, Purification, and Function of the Enzyme"

24. Young-Joo Yi - "Essential Role of Ubiquitin System in Mammalian Fertilization"

25. Jie Yu - "Development of Nrf2 Pharmacodynamic Marker Assay for MLN4924 Clinical Trials"

26. Jinghui Zhao - "mTORC1 Inhibition Activates, and Blocking Protein Synthesis Suppresses, Overall Protein Degradation by Coordinately Altering Both the Ubiquitin-Proteasome Pathway and Autophagy"
                                             
Poster Presentation Information

Registration for the conference is compulsory and can be done via online, phone, fax or mail. Please kindly indicate that you would like to present a poster and provide us with a title of the poster. For our Speakers, Sponsors and Exhibitors, please kindly contact the Poster Coordinator at chew@ubiquitinconference.com.

The poster abstract can be uploaded to the website on the registration site and will only be reviewed by the Program Committee once your registration has been fully processed. To be eligible for a poster presentation, we must receive both your registration fees in full together with the poster abstract before the conference's poster deadline.

30% of the podium presentation will be selected by the program committee from the abstracts that are submitted for poster presentation.

To submit another poster, kindly contact the Poster Coordinator at chew@ubiquitinconference.com.

Poster Abstract Submission Guidelines
To be eligible for a review of your abstract by the Program Committee, 

1. We must receive your registration fees in full and a copy of your poster abstract by the conference's poster deadline.

2. Your abstract should be purely scientific in content and be relevant to the conference topic.

3. Your abstract should be one-page long with a distinguished title, author(s) and the respective affiliations.

4. Please omit images, tables and scientific characters/symbols from the poster abstract, but feel free to use them for your actual poster presentations.

All submitted abstracts are subjected to review and approval of our Program Committee. The decisions made by the Programm Committee are final.

Onsite Poster Guidelines
1. The given dimensions for the poster are 46 inches Wide by 44 inches High.

2. The presenter is solely reponsible for the transportation, setting up and removal of the poster. There are no printing facilities available onsite for this event and the presenter is encouraged to bring a small box of pushpins in case of a short supply of pushpins. At the end of the poster session, VLI will not be responsible for the posters.

3. VLI has no obligation to allocate specific time slots for the poster presentations. The poster sessions area is opened to the attendees throughout the exhibit hours.

Disclaimer
VLI reserves the right to use and publish your poster title and abstract, in whole or part thereof, to be used in any VLI marketing materials or products, including but not limited to, conference flyers and brochures, press releases, websites,program guides, speaker presentation links, CDs, DVDs, and any other sites used by VLI.
 
Poster Coordinator
Tyng Feng Chew (Mr.)
chew@ubiquitinconference.com
610 644 0585 x 304